Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This trial will compare the effectiveness of Docetaxel with or without Carboplatin as second
line chemotherapy in patients with Non-Small Cell Lung Cancer, who have not been treated
previously with Docetaxel.